Astrana Health, Inc. (ASTH) Earnings Call Transcripts

Astrana Health, Inc.'s Latest Earnings Call - Q1 FY2026

Astrana Health, Inc. (ASTH:US) reported a robust first quarter for fiscal year 2026, with revenue of $965.1 million, representing a 56% year-over-year increase, and adjusted EBITDA of $66.3 million, up 82% year-over-year. Non-GAAP adjusted EPS was $0.74, a 76% increase from the previous year. Management reaffirmed full-year guidance, expecting total revenue between $3.8 billion and $4.1 billion and adjusted EBITDA of $250 million to $280 million, signaling confidence in their operational model and growth strategy.

Reported metrics

Guidance from management

Management reaffirmed their full-year 2026 guidance, expecting total revenue between $3.8 billion and $4.1 billion and adjusted EBITDA between $250 million and $280 million, indicating confidence in their operational model and growth strategy.

What management said

Thanks, Ryan. Yes, I think that's unfortunately going to have to wait until later in the year. We don't have an exact date in mind, but probably in the third or fourth quarters. So again, out of conservatism, we've left that contribution out of the guidance for 2026. But we look forward to hearing more and updating the street when that happens.

Yes, that's right, Dave. Prospect was on track for around $80 million of adjusted EBITDA on an annualized basis. And at this point in time, it is currently tracking a bit ahead of those expectations.

What analysts pressed on

Analysts expressed concerns regarding membership trends, particularly in Medicaid and ACA populations, and the potential impact of regulatory changes on future earnings. They sought clarity on how Astrana plans to manage these dynamics moving forward.

Main topics on the call

• Strong Revenue Growth — Astrana reported revenue of $965.1 million, up 56% year-over-year, driven by new full-risk contracts and contributions from the Prospect acquisition. Management stated, "Both revenue and adjusted EBITDA came in at the hi...
• Improved Operating Leverage — G&A as a percentage of revenue improved to 6.4%, down 70 basis points year-over-year, indicating enhanced operational efficiency. Management noted, "We expect additional operating leverage over time and believe that we w...
• Successful Integration of Prospect — The integration of Prospect is on track, with gross provider retention above 99% and expected synergies of $12 million to $15 million annually. Management highlighted that integration continues to validate the strategic ...
• Membership Trends — Membership in value-based care arrangements reached approximately 1.55 million, with 40% of owned membership in full-risk contracts. Management mentioned, "We are pleased with the consistency of our performance and execu...

Read the full Astrana Health, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 41 Astrana Health, Inc. earnings call transcripts on record, spanning November 12, 2020 to August 6, 2026. Based on this history, Astrana Health, Inc. reports quarterly. The most recent call on file is dated August 6, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

ASTH

Exchange

NasdaqCM

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

41

First call

November 12, 2020

Most recent

August 6, 2026

Reporting cadence

quarterly